Green light: A gene therapy trial for Angelman syndrome is set to resume after the FDA suspended it last November. Guido Mieth / Getty Images The US Food and Drug Administration (FDA) has paved the way for the resumption of a clinical trial of gene therapy for Angelman syndrome. The FDA suspended the study last […]
